Downloading...
Download

Himsandhers

S&P Pharmaceutical Sector: A Prescription for Growth● The S&P Pharmaceutical sector has great potential for growth. ● The weekly chart shows that after breaking out of the Symmetrical Triangle Pattern, the ETF had a short period of consolidation and is now ready for a rise. ● The daily chart also indicates a Cup & Handle Pattern, with the price trending upward post-breakout. As the industry revives, certain stocks are ready to achieve similar success Key stocks to watch: Hims & Hers NYSE:HIMS ● The price has broken the trendline resistance with high volume. ● More upward movement is likely to follow. Crinetics Pharmaceuticals NASDAQ:CRNX ● Mirrors HIMS' chart pattern. ● Poised for robust growth after breakout.
AMEX:XPHLong
by NaranjCapital
$HIMS | Allocation | Market Exec |Technical Confluences: - Price action is near the 50% Fibo retracement area - Price action have bounced off the 200 MA (Red) and has a valid Resistance Trendline with an Interest Zone nearby - Stochastics is inn Oversold conditions in the Daily & Weekly timeframes - Elliot Wave 4 seems to be completing at the 50% Fibo line and aim for the 100% Fibo Extension line @ 29.51 Fundamental Confluences: - Telemedicine with US being a focus market is great as healthcare issues seems to be increasing; demographics start to shift right - The main health markets that they target are issues that many in the society prefer to remain anonymous about and telemedicine solves that for them - One negative would be the high expenses they are spending on A&P budgets, a drag but overtime, we can see the impact of what they have been pushing all these while ________________________________ Putting NYSE:HIMS as part of my medical/health category of my portfolio. Will start my first allocation now and look at adding more into it if price moves into 50% - 61% Fibo range (Interest Zone). Remember, DYOR. ________________________________ Boosts 🚀, Follows ✌️, Shares 🙌 & Comments ✍️ are much appreciated! If you have any ideas or charts, do share them in the 'Comments' section below and we can discuss our perspectives to improve or strengthen our strategies. If you want something analyzed, do drop me a DM. :D ________________________________ Disclaimer: The above suggestion is an personal opinion in general and does not constitute as investment advice. Any decisions taken based on the above suggestion is purely your own risks. DYOR.
NYSE:HIMSLong
by weekendanalyst